Mary Tagliaferri - Jun 11, 2024 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role: Director
Signature: /s/ John LaRocca, Attorney-in-Fact
Stock symbol: YMAB
Transactions as of: Jun 11, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/13/2024, 09:02 PM
Previous filing: Mar 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	YMAB	Common Stock	Award	$0	+3.5K	+75%	$0.00	8.16K	Jun 11, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	YMAB	Employee Stock Option (right to buy)	Award	$0	+14.5K		$0.00	14.5K	Jun 11, 2024	Common Stock	14.5K	$12.01	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock on the vesting date of the RSUs. The RSUs vest in full on the earlier of the first anniversary of the date of grant or the date immediately preceding the date of the Issuer's annual meeting of stockholders held in 2025, subject to the Reporting Person's continued service to the Issuer on the vesting date.
F2	Stock options granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan.
F3	The stock options vest in equal monthly installments until the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer on each vesting date, and are exercisable immediately upon vesting.